Can Sporadic Medullary Thyroid Carcinoma Be Biochemically Predicted? Prospective Analysis of 66 Operated Patients with Elevated Serum Calcitonin Levels
暂无分享,去创建一个
[1] H. Holzhausen,et al. Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation , 2000, Langenbeck's Archives of Surgery.
[2] E. Baudin,et al. Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma. , 1999, European journal of endocrinology.
[3] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[4] B. Conte Devolx,et al. Latent Subclinical Medullary Thyroid Carcinoma: Diagnosis and Treatment , 1998, World Journal of Surgery.
[5] M. Schlumberger,et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .
[6] C. Bieglmayer,et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. , 1997, The Journal of clinical endocrinology and metabolism.
[7] P. Caron,et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. , 1997, The Journal of clinical endocrinology and metabolism.
[8] M. Rieu,et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules , 1995, Clinical endocrinology.
[9] B. Franc,et al. C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. , 1994, Human pathology.
[10] A. Pinchera,et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.
[11] A. Vinik,et al. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors. , 1992, Surgery.
[12] M. Brennan,et al. Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. , 1991, The American journal of surgical pathology.
[13] M. Nadji,et al. C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. , 1988, Human pathology.
[14] M. Montesco,et al. Parafollicular C-Cell Hyperplasia. Report of Three Cases in Primary Thyroid Lymphomas , 1988, Tumori.
[15] S. Lindsay,et al. Medullary carcinoma of the thyroid gland. , 1965, Archives of pathology.
[16] E. Baudin,et al. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors. , 1999, The Journal of clinical endocrinology and metabolism.
[17] P. Niccoli,et al. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. , 1997, Annales d'endocrinologie.
[18] V. Livolsi. C cell hyperplasia/neoplasia. , 1997, The Journal of clinical endocrinology and metabolism.
[19] P. Niccoli,et al. [Hypercalcitoninemia in conditions other than medullary cancers of the thyroid]. , 1996, Annales d'endocrinologie.
[20] S. Guyétant,et al. [Non-neoplastic hypercalcitoninemia. Pathological anatomy]. , 1996, Annales d'endocrinologie.
[21] E. Baudin,et al. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. , 1995, European journal of endocrinology.
[22] V. Rohmer,et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.